Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Reddit Inc — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $296.08 (market cap $8.04B), while Reddit Inc trades at $199 (market cap $39.13B). The key difference: Reddit Inc is far larger — about 4.9× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap. Which is the better fit depends on your goals.
| BIO | RDDT | |
|---|---|---|
Market Cap | $8.04B | $39.13B |
Sector | Health | Media |
52-Week High | $339.75 | $270.71 |
52-Week Low | $241.71 | $121.84 |
Enterprise Value | $7.85B | $36.38B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIO trades at $297.58, up 0.5% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $305. The stock shows strong profitability with a 51.87% gross margin and positive net income of $760M in 2025, though recent quarters have seen EPS misses. Cash flow from operations remains robust at $532M, supporting financial stability.
Outlook is cautiously optimistic with analyst support, but risks include earnings volatility and high P/E valuation. The company's return to profitability and solid balance sheet provide a foundation for growth, though investors should monitor execution against future earnings expectations and competitive pressures in the biotech sector.
Reddit (RDDT) trades at $200.71, up 2.71% today, with a bullish technical outlook supported by moving averages and ADX signals. The stock shows strong fundamentals with 45% revenue growth, a 28.6% net income margin, and robust cash flow. Recent news highlights AI safety initiatives and digital ad momentum, while Q2 2026 earnings are anticipated on July 30, 2026.
The investment outlook is positive, driven by earnings beats, analyst consensus of $235.25 price target, and 63% buy ratings. Risks include high valuation multiples and competitive pressures in digital advertising. Upside potential hinges on sustained user engagement and execution of growth strategies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
